Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
tRF-ASO-Exo-PAE in Diabetic Ocular Surface Diseases
NCT07382453Phase 2Not yet recruiting
- Sponsor
- Affiliated Hospital of Nantong University
- Start
- Feb 2026
- Primary completion
- Dec 2028
- Modality
- Modified DNA Oligonucleotides, Lipid-based Nanoparticles, Single-strand DNA
01
Overview
A Phase 2 trial of tRF-ASO-Exo-PAE in Diabetic Ocular Surface Disease, sponsored by Affiliated Hospital of Nantong University. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
tRF-ASO-Exo-PAE
03
Conditions
Diabetic Ocular Surface Disease
Beyond the preview
Go deeper on NCT07382453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07382453.